XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.3
Other Financial Information
 9 Months Ended
Sep. 28, 2025
Other Financial Information [Abstract]  
Other Financial Information Other Financial Information
A. Inventories
The following summarizes the components of Inventories:
(MILLIONS)September 28,
2025		December 31, 2024
Finished goods$4,485 $3,775 
Work-in-process6,038 6,101 
Raw materials and supplies945 976 
Inventories
$11,468 $10,851 
Noncurrent inventories not included above(a)
$2,142 $2,663 
(a)Included in Other noncurrent assets. Based on our current estimates and assumptions, there are no recoverability issues for these amounts.
B. Other Current Liabilities
Other current liabilities include, among other things, amounts payable to BioNTech for the gross profit split for Comirnaty, which totaled $426 million as of September 28, 2025 and $1.3 billion as of December 31, 2024.
C. Supplier Finance Program Obligation
We maintain voluntary supply chain finance agreements with several participating financial institutions. Under these agreements, participating suppliers may voluntarily elect to sell their accounts receivable with Pfizer to these financial institutions. As of September 28, 2025 and December 31, 2024, respectively, $566 million and $688 million of our trade payables to suppliers who participate in these financing arrangements were outstanding.